Sami Ibrahimi to Treatment Outcome
This is a "connection" page, showing publications Sami Ibrahimi has written about Treatment Outcome.
Connection Strength
0.168
-
Sustained response to lenalidomide for early relapsed marginal zone lymphoma. Blood Cells Mol Dis. 2018 07; 71:53-54.
Score: 0.095
-
Harnessing the PD-1 Pathway in Myelodysplastic Syndrome. Am J Ther. 2018 Nov/Dec; 25(6):e711-e712.
Score: 0.025
-
Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma. Am J Ther. 2018 May/Jun; 25(3):e394-e396.
Score: 0.024
-
Extranodal Marginal Zone Lymphoma of the Central Nervous System. Clin Lymphoma Myeloma Leuk. 2018 01; 18(1):34-37.e8.
Score: 0.023